Lv41
630 积分 2023-06-06 加入
Cancer burden and control in China: landscape, trends and challenges
13天前
已完结
IL-18 in atopic dermatitis—a multifaceted driver of skin inflammation
25天前
已完结
The tumor suppressor role and epigenetic regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in cancer and tumor microenvironment (TME)
1个月前
已完结
Recent advances in studies of 15-PGDH as a key enzyme for the degradation of prostaglandins
1个月前
已完结
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
3个月前
已完结
Preclinical development and a phase 1 trial of IMC001, an EpCAM-targeted CAR-T cell therapy, in patients with advanced gastric cancer
3个月前
已完结
Recent advances in radionuclide drug conjugates (RDCs) for cancer theranostics: From targeted design to clinical translation
3个月前
已完结
Diagnosis and treatment of bullous pemphigoid: an expert consensus statement （2025 edition）
4个月前
已完结
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
4个月前
已完结
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
4个月前
已完结
皖公网安备34019202002308
